By letter of 28 September 2016 ISK Biosciences Europe N.V. withdrew its application for the approval of cyclaniliprole.
Par lettre du 28 septembre 2016, ISK Biosciences Europe NV a retiré sa demande d'approbation du cyclaniliprole.